Sponsor Pipeline

Azevan Pharmaceuticals Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07328529 Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome Aggressive Behavior in Fragile X Syndome Not Yet Recruiting
Get alerts when Azevan Pharmaceuticals's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free